Fang Fang

Fang Fang

Auto-generated profile, based on publicly available information

Fang Fang

Genomics and Applied Public Health Center, RTI International, Durham, United States of America

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2011 in Cell
Verified
Journal Article
Closed access
AMAntoine Molaro
Antoine Molaro
EHEmily Hodges
Emily Hodges
FFFang Fang
Fang Fang
QSQiang Song
Qiang Song
WMW. Richard McCombie
W. Richard McCombie
ASAndrew D. Smith
Andrew D. Smith

20 April 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
FFFang Fang
Fang Fang
EHEmily Hodges
Emily Hodges
AMAntoine Molaro
Antoine Molaro
MDMatthew Dean
Matthew Dean
GHGregory J. Hannon
Gregory J. Hannon
ASAndrew D. Smith
Andrew D. Smith
DNA methylation mediates imprinted gene expression by passing an epigenomic state across generations and differentially marking specific regulatory regions on maternal and paternal alleles. Imprinting has been tied to the evolution of the placenta in mammals and defects of imprinting have been associated with human diseases. Although recent advances in genome sequencing have revolutionized the study of DNA methylation, existing methylome data remain largely untapped in the study of imprinting. We present a statistical model to describe allele-specific methylation (ASM) in data from high-throughput short-read bisulfite sequencing. Simulation results indicate technical specifications of existing methylome data, such as read length and coverage, are sufficient for full-genome ASM profiling based on our model. We used our model to analyze methylomes for a diverse set of human cell types, including cultured and uncultured differentiated cells, embryonic stem cells and induced pluripotent stem cells. Regions of ASM identified most consistently across methylomes are tightly connected with known imprinted genes and precisely delineate the boundaries of several known imprinting control regions. Predicted regions of ASM common to multiple cell types frequently mark noncoding RNA promoters and represent promising starting points for targeted validation. More generally, our model provides the analytical complement to cutting-edge experimental technologies for surveying ASM in specific cell types and across species.

1 July 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
GPGrier Page
Grier Page
TKTamir Kanias
Tamir Kanias
YGYuelong J. Guo
Yuelong J. Guo
MLMarion C. Lanteri
Marion C. Lanteri
XZXu Zhang
Xu Zhang
MGMark T. Gladwin
Mark T. Gladwin
Background. The evolutionary pressure of endemic malaria and other erythrocytic pathogens has shaped variation in genes encoding erythrocyte structural and functional proteins, influencing responses to hemolytic stress during transfusion and disease. Methods. We sought to identify such genetic variants in blood donors by conducting a genome-wide association study (GWAS) of 12,353 volunteer donors, including 1,406 African Americans, 1,306 Asians, and 945 Hispanics, whose stored erythrocytes were characterized by quantitative assays of in vitro osmotic, oxidative, and cold-storage hemolysis. Results. GWAS revealed 27 significant loci (P < 5 × 10–8), many in candidate genes known to modulate erythrocyte structure, metabolism, and ion channels, including SPTA1, ALDH2, ANK1, HK1, MAPKAPK5, AQP1, PIEZO1, and SLC4A1/band 3. GWAS of oxidative hemolysis identified variants in genes encoding antioxidant enzymes, including GLRX, GPX4, G6PD, and SEC14L4 (Golgi-transport protein). Genome-wide significant loci were also tested for association with the severity of steady-state (baseline) in vivo hemolytic anemia in patients with sickle cell disease, with confirmation of identified SNPs in HBA2, G6PD, PIEZO1, AQP1, and SEC14L4. Conclusions. Many of the identified variants, such as those in G6PD, have previously been shown to impair erythrocyte recovery after transfusion, associate with anemia, or cause rare Mendelian human hemolytic diseases. Candidate SNPs in these genes, especially in polygenic combinations, may affect RBC recovery after transfusion and modulate disease severity in hemolytic diseases, such as sickle cell disease and malaria.

11 January 2022 in JCI Insight
Verified
Journal Article
Open access
PDF file
NRNareg H. Roubinian
Nareg H. Roubinian
SRSarah E. Reese
Sarah E. Reese
HQHannah Qiao
Hannah Qiao
CPColleen Plimier
Colleen Plimier
FFFang Fang
Fang Fang
EHEldad A. Hod
Eldad A. Hod
BACKGROUND: RBC transfusion effectiveness varies due to donor, component, and recipient factors. Prior studies identified characteristics associated with variation in hemoglobin increments following transfusion. We extended these observations, examining donor genetic and nongenetic factors affecting transfusion effectiveness. METHODS: This is a multicenter retrospective study of 46,705 patients and 102,043 evaluable RBC transfusions from 2013 to 2016 across 12 hospitals. Transfusion effectiveness was defined as hemoglobin, bilirubin, or creatinine increments following single RBC unit transfusion. Models incorporated a subset of donors with data on single nucleotide polymorphisms associated with osmotic and oxidative hemolysis in vitro. Mixed modeling accounting for repeated transfusion episodes identified predictors of transfusion effectiveness. RESULTS: Blood donor (sex, Rh status, fingerstick hemoglobin, smoking), component (storage duration, γ irradiation, leukoreduction, apheresis collection, storage solution), and recipient (sex, BMI, race and ethnicity, age) characteristics were associated with hemoglobin and bilirubin, but not creatinine, increments following RBC transfusions. Increased storage duration was associated with increased bilirubin and decreased hemoglobin increments, suggestive of in vivo hemolysis following transfusion. Donor G6PD deficiency and polymorphisms in SEC14L4 , HBA2 , and MYO9B genes were associated with decreased hemoglobin increments. Donor G6PD deficiency and polymorphisms in SEC14L4 were associated with increased transfusion requirements in the subsequent 48 hours. CONCLUSION: Donor genetic and other factors, such as RBC storage duration, affect transfusion effectiveness as defined by decreased hemoglobin or increased bilirubin increments. Addressing these factors will provide a precision medicine approach to improve patient outcomes, particularly for chronically transfused RBC recipients, who would most benefit from more effective transfusion products. FUNDING: Funding was provided by HHSN 75N92019D00032, HHSN 75N92019D00034, 75N92019D00035, HHSN 75N92019D00036, and HHSN 75N92019D00037; R01HL126130; and the National Institute of Child Health and Human Development (NICHD).

1 July 2018 in Experimental Gerontology
Verified
Journal Article
Closed access
AYAnatoliy I. Yashin
Anatoliy I. Yashin
FFFang Fang
Fang Fang
MKMikhail Kovtun
Mikhail Kovtun
DWDeqing Wu
Deqing Wu
MDMatt Duan
Matt Duan
SUSvetlana Ukraintseva
Svetlana Ukraintseva

1 November 2016 in Cell Reports
Verified
Journal Article
Open access
NGNicholas C. Gomez
Nicholas C. Gomez
AHAustin J. Hepperla
Austin J. Hepperla
RDRaluca Dumitru
Raluca Dumitru
JSJeremy M. Simon
Jeremy M. Simon
FFFang Fang
Fang Fang
IDIan J. Davis
Ian J. Davis
Chromatin regulation is critical for differentiation and disease. However, features linking the chromatin environment of stem cells with disease remain largely unknown. We explored chromatin accessibility in embryonic and multipotent stem cells and unexpectedly identified widespread chromatin accessibility at repetitive elements. Integrating genomic and biochemical approaches, we demonstrate that these sites of increased accessibility are associated with well-positioned nucleosomes marked by distinct histone modifications. Differentiation is accompanied by chromatin remodeling at repetitive elements associated with altered expression of genes in relevant developmental pathways. Remarkably, we found that the chromatin environment of Ewing sarcoma, a mesenchymally derived tumor, is shared with primary mesenchymal stem cells (MSCs). Accessibility at repetitive elements in MSCs offers a permissive environment that is exploited by the critical oncogene responsible for this cancer. Our data demonstrate that stem cells harbor a unique chromatin landscape characterized by accessibility at repetitive elements, a feature associated with differentiation and oncogenesis.